Screening for Diabetic Retinopathy
Open accessAbstract
Throughout the industrialized world the complications of diabetic retinopathy remain the major cause of preventable visual loss in persons of working age. A reduction by one-third or more in new blindness due to diabetes has been adopted as one of the key 5-year targets in the St Vincent declaration,1 and the best way to achieve this aim is a national strategy of screening for diabetic retinopathy. In this article we review the rationale and supporting evidence for a screening programme for diabetic retinopathy. We also debate the arguments for and against the screening modalities that are currently used in the UK.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
UK and Australia recommendations suggested a minimum sensitivity of either 80% or 60%, and a specificity of at least 95%.
“In the UK and Australia, previous recommendations suggested a minimum sensitivity of either 80% or 60%, and a specificity of at least 95%25–30.”
From Economic evaluation for medical artificial intelligence: accuracy vs. cost-effectiveness in a diabetic retinopathy screening case (2024) · cites this paper as [26]
Cited by
Sorted by citations
Wang, Y., Liu, C., Hu, W., Luo, L., Shi, D., Zhang, J., Yin, Q., Zhang, L., Han, X., & He, M. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01032-9 · Cited by 76 · see citing works
Piyasena, M. M. P. N., Yip, J. L. Y., MacLeod, D., Kim, M., & Gudlavalleti, V. S. M. (2019) · BMC Ophthalmology · doi:10.1186/s12886-019-1092-3 · Cited by 70 · see citing works
- Authors
- Squirrell, D. M., & Talbot, J. F.
- Affiliations
- Royal Hallamshire Hospital (GB)
- ORCID
- Squirrell, D M
- Venue
- Journal of the Royal Society of Medicine
- Publisher
- SAGE Publications
- Published
- 2003-06
- Volume
- 96
- Issue
- 6
- Pages
- 273-276
- ISSN
- 0141-0768 (ISSN-L)
- 1758-1095
- PMC
- PMC539506
- OpenAlex
- W2090777308
- Cited by
- 51
- References
- 0
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 9 · 2022: 6 · 2021: 7 · 2020: 2 · 2019: 6 · 2018: 4 · 2017: 3 · 2016: 3 · 2015: 2 · 2014: 2 · 2012: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of the Royal Society of Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- diabetic retinopathy, screening, blindness prevention, vision loss, St. Vincent Declaration, screening method, diabetes complications
- MeSH terms
- Blindness, Diabetic Retinopathy, United Kingdom, Humans, Photography, Vision Screening, Laser Coagulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
